Uri Aharon - RedHill Biopharma Insider

RDHL -- USA Stock  

USD 8.00  0.14  1.78%

Mr. Uri Hananel Aharon serves as Chief Accounting Officer at Redhill Biopharma Ltd, effective since 2012. His work experience includes the following roles Team Manager at Ernst Young Israel and Accounting Intern at Ziv Haft, BDO . He holds a Bachelors degree in Accounting and Economics from The Hebrew University of Jerusalem and a MBA degree, majoring in Business Taxation, from the College of Management Academic Studies, Rishon LeZion.
Age: 35  Executive Since 2011  MBA    
972 3 541 3131  http://www.redhillbio.com
Aharon is a graduate of the Hebrew University and the Academic College for Management, Rishon Lezion .

Management Efficiency

The company has return on total asset (ROA) of (54.98) % which means that it has lost $54.98 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (98.45) % meaning that it created substantial loss on money invested by shareholders.

Similar Executives

Showing few of many executives


Haig BozigianNeurocrine Biosciences
Christopher OBrienNeurocrine Biosciences
Nuria BarnesGrifols S A
Karen SmithJazz Pharmaceuticals Public Lim
Malcolm LloydSmithNeurocrine Biosciences
Raimon RouraGrifols S A
Darin LippoldtNeurocrine Biosciences
Dimitri GrigoriadisNeurocrine Biosciences
Mark DehringCSL Limited
Jane SorensenNeurocrine Biosciences
Julie CookeNeurocrine Biosciences
Navjot RaiNeurocrine Biosciences
Montserrat CalvoGrifols S A
Eric BenevichNeurocrine Biosciences
Arvind SoodAmgen
Bernard RonchiCSL Limited
Miguel MontblanchGrifols S A
John LevyCSL Limited
Edward BaileyCSL Limited
Fiona MeadCSL Limited
Kyle GanoNeurocrine Biosciences

Entity Summary

RedHill Biopharma Ltd., a specialty biopharmaceutical company, focuses on the development and commercialization of late clinical-stage drugs for the treatment of gastrointestinal diseases. The company was founded in 2009 and is headquartered in Tel Aviv, Israel. RedHill Biopharma operates under Biotechnology classification in USA and traded on Nasdaq Capital Markets. It employs 74 people.RedHill Biopharma Ltd (RDHL) is traded on Nasdaq Capital Markets in USA. It is located in 21 Ha'arba'a Street and employs 74 people.

RedHill Biopharma Leadership Team

Patricia Anderson, Vice President - Regulatory Affairs
Micha Chorin, CFO
Ofer Tsimchi, Director
Patrick Mclean, Product Manager
Aida Bibliowicz, Vice President - Clinical Affairs Europe
Ori Shilo, Co-Founder and Deputy CEO of Fin. and Operations
Shmuel Cabilly, Director
Dror BenAsher, Chairman of the Board, CEO
Kenneth Reed, Director
Elkan Gamzu, Product Manager
Adi Frish, Sr. VP of Bus. Devel. and Licensing
Guy Goldberg, Chief Business Officer
Reza Fathi, Sr. VP of RandD
Tom Lang, Vice President - Regulatory & Clinical Affairs
Clara Fehrmann, Product Manager
Pascal Weerts, Director - Corporate and Legal Affairs
Eric Swenden, Director
Dan Suesskind, Director
Gilead Raday, Senior Vice President - Product and Corporate Development
Rick Scruggs, Director
Terry Plasse, Medical Director
Danielle Abramson, Director - Intellectual Property & Research
Uri Aharon, Chief Accounting Officer
Shani Maurice, Vice President - Business Development & Communications
Patricia Bandeira, Product Manager - Oncology
Ira Kalfus, Medical Director
Nurit Benjamini, External Director

Stock Performance Indicators

Current Sentiment - RDHL

RedHill Biopharma Investor Sentiment

Most of Macroaxis users are at this time bullish on RedHill Biopharma Ltd. What is your perspective on investing in RedHill Biopharma Ltd? Are you bullish or bearish?
98% Bullish
2% Bearish
Currently Active Assets on Macroaxis
Purchased over 400 shares of
few hours ago
Traded for 6.36
Purchased a lot of shares of
few hours ago
Traded for 153.4
Purchased few shares of
few hours ago
Traded for 1161.22
Purchased over 100 shares of
few hours ago
Traded for 29.52
Purchased over 20 shares of
few hours ago
Traded for 111.7
Additionally take a look at Your Equity Center. Please also try Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Search macroaxis.com